Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients
19th International Conference on Neurology and Neurological Disorders
November 04-05, 2019 | Melbourne, Australia
Jade Kenna, Sarah McGregor, Malcolm Horne, Alfred Tay, Alexa Jefferson, Souyma Ghosh, Frank Mastaglia, Megan Bakeberg, Anastazja Gorecki, Sue Walters, Ryan Anderton
Perron Institute for Neurological and Translational Science, Australia University of Western Australia, Australia St Vincent’s Hospital Melbourne, Australia University of Melbourne, Australia University of Notre Dame Australia, Australia
Scientific Tracks Abstracts : J Neurol Neurorehabil Res
Abstract:
Parkinson’s disease (PD) is associated with an assortment
of difficult to recognize non-motor symptoms, including
gastrointestinal (GI) dysfunction. Recently, there have been
studies reporting the appearance of GI symptoms up to
two decades prior to motor symptom onset in patients. To
date, limited number of studies have reported an association
between an altered microbiota composition and PD. Despite
this emerging relationship, it remains to be seen if this
association exists in Australian patients with PD. This study
involved a multi-centre assessment and recruitment of 120
patients with diagnosed PD from St Vincent’s Movement
Disorders Clinic (Fitzroy, VIC), the Perron Institute Movement
Disorders Clinic (Nedlands, WA). The Movement Disorders
Society Unified Parkinson’s Disease Rating Scale (MDSUPDRS)
was used to determine disease severity, including
motor and non-motor symptoms. Global cognitive function
was measure using Addenbrooke’s Cognitive Exam-Revised
(ACE-R), and Scales for Outcomes in Parkinson’s disease
Assessment. In collaboration with the Marshall Centre
(UWA, WA), this study aimed to determine if the gut
microbial composition differed between PD patients and
age-matched healthy controls using targeted sequencing of
the V3 and V4 regions of 16s ribosomal RNA (rRNA) gene.
Microbiome diversity, determined by operational taxonomic
units (OTUs) and relative abundance were examined for an
association with patient clinical assessment outcomes, using
a multivariate regression analysis.
Our current results identified that both relative abundance
and diversity of microbial OTUs were significantly different in
patients with PD when compared to healthy controls (p<0.05).
Specifically, Verrucomicrobia and Gammaproteobacterial
were both increased within PD. Within the patient cohort,
reduced microbial diversity was significantly associated with
elevated MDS-UPDRS III scores, and decreased quality of life.
This project provides the first comprehensive characterisation
of the microbial diversity and composition in an Australian
cohort of PD patients. The preliminary findings from this
study support previous results and show associations
between microbial diversity and patient clinical outcomes,
further exploring the gut-brain connection in the progression
and management of this disease.
Biography:
Jade Kenna is currently in her second year of her PhD in Clinical Neuroscience through the Medical School at The University of Western Australia and The Perron Institute. Her PhD project is the first in Australia to investigate the role of the gut microbiome in a cohort of Parkinson’s disease patients from multiple locations around Australia. She has experience presenting oral and poster presentations at national and international conferences. She has been working as a research assistant and laboratory demonstrator alongside completing her PhD and has received Letters from the University’s Dean each semester for outstanding teaching performance every semester. In addition, she continues to volunteer for university events and charities, and assists in organizing and operation of many events, such as the inaugural Perron Institute Research Symposium.
E-mail: jade.kenna@research.uwa.edu.au
PDF HTML